Convergence Rates of Spectral Distribution of Random Inner Product Kernel Matrices
Genre
Thesis/DissertationDate
2018Author
Kong, NayeongAdvisor
Rider, Brian (Brian C.)Committee member
Yang, Wei-shih, 1954-Berhanu, Shiferaw
Mukhopadhyay, Subhadeep
Department
MathematicsSubject
MathematicsProbability
Random Geometric Graph
Random Graph
Random Inner Product Kernel Matrix
Random Matrix
Spectral Distribution
Permanent link to this record
http://hdl.handle.net/20.500.12613/3132
Metadata
Show full item recordDOI
http://dx.doi.org/10.34944/dspace/3114Abstract
This dissertation has two parts. In the first part, we focus on random inner product kernel matrices. Under various assumptions, many authors have proved that the limiting empirical spectral distribution (ESD) of such matrices A converges to the Marchenko- Pastur distribution. Here, we establish the corresponding rate of convergence. The strategy is as follows. First, we show that for z = u + iv ∈ C, v > 0, the distance between the Stieltjes transform m_A (z) of ESD of matrix A and Machenko-Pastur distribution m(z) is of order O (log n \ nv). Next, we prove the Kolmogorov distance between ESD of matrix A and Marchenko-Pastur distribution is of order O(3\log n\n). It is the less sharp rate for much more general class of matrices. This uses a Berry-Esseen type bound that has been employed for similar purposes for other families of random matrices. In the second part, random geometric graphs on the unit sphere are considered. Observing that adjacency matrices of these graphs can be thought of as random inner product matrices, we are able to use an idea of Cheng-Singer to establish the limiting for the ESD of these adjacency matrices.ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduCollections
Related items
Showing items related by title, author, creator and subject.
-
A phase III randomized three-arm trial of physical therapist delivered pain coping skills training for patients with total knee arthroplasty: The KASTPain protocolRiddle, DL; Keefe, FJ; Ang, D; J, K; Dumenci, L; Jensen, MP; Bair, MJ; Reed, SD; Kroenke, K (2012-08-27)Abstract. Background: Approximately 20% of patients report persistent and disabling pain following total knee arthroplasty (TKA) despite an apparently normally functioning prosthesis. One potential risk factor for unexplained persistent pain is high levels of pain catastrophizing. We designed a three-arm trial to determine if a pain coping skills training program, delivered prior to TKA, effectively reduces function-limiting pain following the procedure in patients with high levels of pain catastrophizing. Methods/design. The trial will be conducted at four University-based sites in the US. A sample of 402 patients with high levels of pain catastrophizing will be randomly assigned to either a pain coping skills training arm, an arthritis education control arm or usual care. Pain coping skills will be delivered by physical therapists trained and supervised by clinical psychologist experts. Arthritis education will be delivered by nurses trained in the delivery of arthritis-related content. The primary outcome will be change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain scale score 12 months following surgery. A variety of secondary clinical and economic outcomes also will be evaluated. Discussion. The trial will be conducted at four University-based sites in the US. A sample of 402 patients with high levels of pain catastrophizing will be randomly assigned to either a pain coping skills training arm, an arthritis education control arm or usual care. Pain coping skills will be delivered by physical therapists trained and supervised by clinical psychologist experts. Arthritis education will be delivered by nurses trained in the delivery of arthritis-related content. The primary outcome will be change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain scale score 12 months following surgery. A variety of secondary clinical and economic outcomes also will be evaluated. Trial Registration. NCT01620983. © 2012 Riddle et al.; licensee BioMed Central Ltd.
-
A Nonparametric Test for Deviation from RandomnessIglewicz, Boris; Chitturi, Pallavi; Dong, Yuexiao; Chervoneva, Inna (Temple University. Libraries, 2012)There are many existing tests used to determine if a series consists of a random sample. Often these tests have restrictive distributional assumptions, size distortions, or low power for key useful alternative situations. The interest of this dissertation lies in developing an alternative nonparametric test to determine whether a series consists of a random sample. The proposed test detects deviations from randomness, without a priori distributional assumption, when observations are not independent and identically distributed (i.i.d.), which is suitable for our motivating stock market index data. Departures from i.i.d. are tested by subdividing data into subintervals and then using a conditional probability measure within intervals as a binomial test. This nonparametric test is designed to detect deviations of neighboring observations from randomness when the data set consists of time series observations. Simulation results confirm correct test size for varied distributions and good power for detecting alternative cases. This test is compared to a number of other popular methods and shown to be a competitive alternative. Although the proposed test may be applicable to multiple areas, this dissertation is mostly interested in applications to stock market and regression data. The proposed test is effectively illustrated with the common three stock market index data sets using a newly created transformation, and shown to perform exceptionally well.
-
Stimulant Reduction Intervention using Dosed Exercise (STRIDE) - CTN 0037: Study protocol for a randomized controlled trialTrivedi, MH; Greer, TL; Grannemann, BD; Church, TS; Somoza, E; Blair, SN; Szapocznik, J; Stoutenberg, M; Rethorst, C; Warden, D; Ring, KM; Walker, R; Morris, DW; Kosinski, AS; Kyle, T; Marcus, B; Crowell, B; Oden, N; Nunes, E; Stoutenberg, Mark|0000-0001-5206-7627 (2011-09-19)Background: There is a need for novel approaches to the treatment of stimulant abuse and dependence. Clinical data examining the use of exercise as a treatment for the abuse of nicotine, alcohol, and other substances suggest that exercise may be a beneficial treatment for stimulant abuse, with direct effects on decreased use and craving. In addition, exercise has the potential to improve other health domains that may be adversely affected by stimulant use or its treatment, such as sleep disturbance, cognitive function, mood, weight gain, quality of life, and anhedonia, since it has been shown to improve many of these domains in a number of other clinical disorders. Furthermore, neurobiological evidence provides plausible mechanisms by which exercise could positively affect treatment outcomes. The current manuscript presents the rationale, design considerations, and study design of the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) study.Methods/Design: STRIDE is a multisite randomized clinical trial that compares exercise to health education as potential treatments for stimulant abuse or dependence. This study will evaluate individuals diagnosed with stimulant abuse or dependence who are receiving treatment in a residential setting. Three hundred and thirty eligible and interested participants who provide informed consent will be randomized to one of two treatment arms: Vigorous Intensity High Dose Exercise Augmentation (DEI) or Health Education Intervention Augmentation (HEI). Both groups will receive TAU (i.e., usual care). The treatment arms are structured such that the quantity of visits is similar to allow for equivalent contact between groups. In both arms, participants will begin with supervised sessions 3 times per week during the 12-week acute phase of the study. Supervised sessions will be conducted as one-on-one (i.e., individual) sessions, although other participants may be exercising at the same time. Following the 12-week acute phase, participants will begin a 6-month continuation phase during which time they will attend one weekly supervised DEI or HEI session. Clinical Trials Registry: ClinicalTrials.gov, NCT01141608. http://clinicaltrials.gov/ct2/show/NCT01141608?term=Stimulant+Reduction+Intervention+using+Dosed+Exercise&rank=1. © 2011 Trivedi et al; licensee BioMed Central Ltd.